2004
DOI: 10.2337/diabetes.53.1.214
|View full text |Cite
|
Sign up to set email alerts
|

Lipoprotein Lipase Is a Gene for Insulin Resistance in Mexican Americans

Abstract: The insulin resistance syndrome is increasingly recognized as a risk factor for cardiovascular disease. Lipoprotein lipase (LPL) is a candidate gene for components of the syndrome. A small number of studies have demonstrated association of single nucleotide polymorphisms within LPL and indirect or surrogate measures of insulin resistance, largely based on glucose and insulin values obtained in the fasting state or during an oral glucose tolerance test. To test directly whether LPL is an insulin resistance gene… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
74
1

Year Published

2004
2004
2023
2023

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 100 publications
(78 citation statements)
references
References 42 publications
3
74
1
Order By: Relevance
“…Although not convincing, together with the powerful correlation between significantly decreased catalytic activity (B60% of the wild type) and secretion ability (about 50% of the wild type) of N291S mutant and deleterious lipid profile (triglycerides: 32.3% increase and HDL-C: 34.2% decrease), which are risk factors of T2D and CHD, this association may be not a false-positive result and further study is necessary and justifiable. 24 Goodarzi et al 25 analyzed haplotypes of six polymorphisms in LPL and provided compelling evidence that the LPL gene might have a role in determining insulin sensitivity (P¼0.031, haplotype 1: GATTCG) and insulin resistance (P¼0.007, haplotype 4: GAGGGG) in their MexicanAmerican population. Transgenic (Tg) watanabe heritable hyperlipidemic (WHHL) rabbits that overexpress the human LPL gene were generated by Koike et al In addition to dramatically ameliorating hypertriglyceridemia and hypercholesterolemia, overexpression of LPL was able to suppress high-diet-induced obesity and insulin resistance in these Tg WHHL rabbits.…”
Section: Lpl and T2dmentioning
confidence: 99%
“…Although not convincing, together with the powerful correlation between significantly decreased catalytic activity (B60% of the wild type) and secretion ability (about 50% of the wild type) of N291S mutant and deleterious lipid profile (triglycerides: 32.3% increase and HDL-C: 34.2% decrease), which are risk factors of T2D and CHD, this association may be not a false-positive result and further study is necessary and justifiable. 24 Goodarzi et al 25 analyzed haplotypes of six polymorphisms in LPL and provided compelling evidence that the LPL gene might have a role in determining insulin sensitivity (P¼0.031, haplotype 1: GATTCG) and insulin resistance (P¼0.007, haplotype 4: GAGGGG) in their MexicanAmerican population. Transgenic (Tg) watanabe heritable hyperlipidemic (WHHL) rabbits that overexpress the human LPL gene were generated by Koike et al In addition to dramatically ameliorating hypertriglyceridemia and hypercholesterolemia, overexpression of LPL was able to suppress high-diet-induced obesity and insulin resistance in these Tg WHHL rabbits.…”
Section: Lpl and T2dmentioning
confidence: 99%
“…Several indices of insulin sensitivity were obtained, including fasting insulin, glucose infusion rate (GINF) over the last 30 minutes of steady-state insulin and glucose concentrations, and the insulin sensitivity index (S I ), obtained by dividing GINF by body surface area and the increment in plasma insulin from baseline to steady state. 14 …”
Section: Phenotypingmentioning
confidence: 99%
“…14 Family samples were ascertained through a proband with documented coronary artery disease. 14,15 Two generations were enrolled into the study: the proband and proband spouses (parental generation), and their adult (age 18 years or older) offspring and the spouses of those offspring (offspring generation). The offspring were free of diabetes and clinically manifest coronary artery disease, thus avoiding secondary changes in phenotype caused by overt disease.…”
Section: Subjectsmentioning
confidence: 99%
“…108 For example, use of the euglycemic clamp combined with the haplotype approach described has enabled identification of the lipoprotein lipase gene as a gene for insulin resistance. 62 Other detailed phenotypes include the aldosterone response to angiotensin II infusion (the modulating/nonmodulating phenotype) in hypertension 49 and LDL particle size in dyslipidemia. 40,41 Twin studies have traditionally been considered the "gold standard" of human genetic analyses.…”
Section: Genetic Markers: Approaches To Defining Cardiovascular Diseamentioning
confidence: 99%